Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.
Press releases published on August 7, 2025
J-Star Holding Announces Closing of Underwriters’ Over-Allotment Option in Connection with Initial Public Offering
GlobeNewswire
·
August 7, 2025
TAICHUNG CITY, Taiwan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, …
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
GlobeNewswire
·
August 7, 2025
BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appointment of Tim Scannell, former President …
[Latest] Global Women’s Health Rehabilitation Products Market Size Envisioned at USD 9.68 Billion by 2034, Increasing a CAGR of 6.6% | Healthcare Revolution
GlobeNewswire
·
August 7, 2025
NEW YORK, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Women's Health Rehabilitation Products Market By Product (Breast Cancer Care, Chronic Pelvic Pain, Orthopedic Care, Prenatal and Postnatal …
Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial
GlobeNewswire
·
August 7, 2025
- Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track as projected for Q4 2025 - - Low discontinuation rate (6%) due to adverse events amongst the first 35 patients completing the trial suggests …
Postoperative Pain Management Market Poised for Transformation During the Forecast Period (2025–2034) with Rising Non-Opioid Adoption | DelveInsight
GlobeNewswire
·
August 7, 2025
New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Postoperative Pain Management Market Poised for Transformation During the Forecast Period (2025–2034) with Rising Non-Opioid Adoption | DelveInsight The postoperative pain management market is witnessing …
Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight
GlobeNewswire
·
August 7, 2025
New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight The cancer cachexia therapeutics market is gaining traction due to the rising global …
PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET
GlobeNewswire
·
August 7, 2025
MINNEAPOLIS, MN, US, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on …
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
GlobeNewswire
·
August 7, 2025
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 7 August 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer …
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
GlobeNewswire
·
August 7, 2025
Press Release – No. 11 / 2025 Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results Copenhagen, Denmark, August 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a …
Genmab Announces Financial Results for the First Half of 2025
GlobeNewswire
·
August 7, 2025
August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epcoritamab plus R2 in patients with relapsed or refractory …
Hemp Feed Coalition Secures AAFCO Official Publication for Hemp Seed Meal in Poultry Feed
GlobeNewswire
·
August 7, 2025
Omaha, NE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Despite this achievement, HFC and its members stress that the regulatory path to market for hemp feed remains riddled with bureaucratic obstacles. Because AAFCO’s approval alone does not grant automatic state- …
Shineco, Inc. to Effect 50:1 Reverse Stock Split
GlobeNewswire
·
August 7, 2025
Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price BEIJING, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (Nasdaq:SISI) ("Shineco" or the "Company"), a provider of innovative diagnostic medical products and related medical …
WeightWatchers Appoints SoulCycle Co-Founder Julie Rice as Chief Experience Officer to Lead Community and Brand Innovation
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced that longserving WW board member Julie Rice, the entrepreneur and …
Allergy Diagnostics and Treatments Market to Reach $96.4 Billion by 2030
GlobeNewswire
·
August 7, 2025
Boston, Aug. 07, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Markets for Allergy Diagnostics and Treatments” is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual …
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
GlobeNewswire
·
August 7, 2025
Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival (HR …
Alkeus Pharmaceuticals Announces Presentation of Positive Interim TEASE-3 Study Data in Early-Stage Stargardt Disease Patients Treated with Oral Gildeuretinol
GlobeNewswire
·
August 7, 2025
Gildeuretinol acetate demonstrated less loss in ellipsoid zone (EZ) area compared to historical sibling controls. Early-stage Stargardt disease patients treated with gildeuretinol for two to seven years exhibited relatively stable disease over the course …
Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
GlobeNewswire
·
August 7, 2025
CT-155 showed a reduction in experiential negative symptoms as an adjunct to standard of care antipsychotic therapy from baseline to week 16, as measured by CAINS-MAP. CT-155 is an investigational prescription digital therapeutic being evaluated to target …
Vibrant Gastro Announces Federal Supply Schedule Contract Approval, Expanding Access to Veterans and Federal Health Patients
GlobeNewswire
·
August 7, 2025
Austin, TX, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Vibrant Gastro, inventor of the Vibrant® System, today announced that its FDA‑cleared, drug‑free treatment for chronic idiopathic constipation (CIC) is now available on the General Services Administration’s ( …
Rheumatologists Eagerly Anticipate Pipeline Advancements in Idiopathic Inflammatory Myopathies to Address Deep Unmet Need, According to Spherix Global Insights
GlobeNewswire
·
August 7, 2025
EXTON, PA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Despite recent increased use of intravenous immunoglobulin (IVIg) and biologics, the majority of patients with idiopathic inflammatory myopathies (IIM)—including classic dermatomyositis (DM), polymyositis (PM), …
Recovery.com Acquires Recovery Brands Care Navigation Platform from American Addiction Centers in Eight-Figure Deal to Expand Access to Care
GlobeNewswire
·
August 7, 2025
MADISON, Wis., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Recovery.com and American Addiction Centers (AAC) today announced the sale and transition of several leading addiction treatment care navigation websites from AAC subsidiary Recovery Brands to Recovery.com. …